Clinical Trials Logo
  1. Home
  2. Spinal Muscular Atrophy
  3. NCT03554343
  4. Details
NCT03554343 Clinical Trial

Sun May Arise on SMA : Newborn Screening of Spinal Muscular Atrophy in Belgium

Spinal Muscular Atrophy Clinical Trial

Official title:
Sun May Arise on SMA : Newborn Screening of SMA in Belgium

Clinical Trial Details — Status: Completed

Administrative data
NCT number NCT03554343
Other study ID # B412201734396
Secondary ID
Status Completed
Phase
First received
Last updated
Start date March 5, 2018
Est. completion date February 28, 2021

Study information
Verified date March 2021
Source Centre Hospitalier Régional de la Citadelle
Contact n/a
Is FDA regulated No
Health authority
Study type Observational

Clinical Trial Summary

Medico-economic study of Newborn screening of Spinal Muscular Atrophy

Description:

The aim of this project is to demonstrate the feasibility and the medico-economic impact of a spinal muscular atrophy neonatal screening in a European country. We propose a 3-year-neonatal screening program in Southern Belgium (Wallonia-Brussels Federation) where there is 59.000 newborns/year, among whom 6 are affected by spinal muscular atrophy.

Recruitment information / eligibility
Status Completed
Enrollment 136339
Est. completion date February 28, 2021
Est. primary completion date February 28, 2021
Accepts healthy volunteers No
Gender All
Age group N/A to 7 Days
Eligibility Inclusion Criteria: - All newborns in southern Belgium Exclusion Criteria: - Newborns whose parents refuse screening

Study Design

Related Conditions & MeSH terms

Intervention

Diagnostic Test:
• test for SMN1 exon 7 deletion
Newborns are screened for SMN1 exon 7 deletion through standard NBS practice Positive case are promptly referred to reference centers

Locations
Country Name City State
Belgium CRMN, Hôpital La Citadelle Liege Wallonia

Sponsors (5)
Lead Sponsor Collaborator
Centre Hospitalier Régional de la Citadelle Association Belge contre les Maladies neuro Musculaires, AveXis, Inc., Biogen, Roche Pharma AG

Country where clinical trial is conducted

Belgium, 

References & Publications (1)

Boemer F, Caberg JH, Dideberg V, Dardenne D, Bours V, Hiligsmann M, Dangouloff T, Servais L. Newborn screening for SMA in Southern Belgium. Neuromuscul Disord. 2019 May;29(5):343-349. doi: 10.1016/j.nmd.2019.02.003. Epub 2019 Feb 15. — View Citation

Outcome
Type Measure Description Time frame Safety issue
Primary Cases detected Number of cases detected, false negative and false positive cases march 2018-March 2021
Secondary Incidence of SMA to gather epidemiological data on SMA in Wallonia-Brussels Federation (carrier frequency, number of cases/year). March 2018-March 2021
See also
  Status Clinical Trial Phase
Completed NCT04851873 - Safety and Efficacy of Intravenous OAV101 (AVXS-101) in Pediatric Patients With Spinal Muscular Atrophy (SMA) Phase 3
Completed NCT03223051 - Development of a Space Exploration Assessment for Children With Spinal Muscular Atrophy N/A
Completed NCT04335942 - Characterization of the Postural Habits of Wheelchair Users Analysis of the Acceptability of International Recommendations in the Prevention of Pressure Sores Risk by Using a Connected Textile Sensor N/A
Recruiting NCT05794139 - Safety and Efficacy of NMD670 in Ambulatory Adult Patients With Type 3 Spinal Muscular Atrophy Phase 2
Not yet recruiting NCT06300996 - Spinal Cord Stimulation for the Treatment of Motor Deficits in People With Spinal Muscular Atrophy - Upper Limb N/A
Not yet recruiting NCT00961103 - Motor Development and Orthoses in Spinal Muscular Atrophy (SMA) N/A
Completed NCT02003937 - Aerobic Training in Patients With Spinal Muscular Atrophy Type III N/A
Completed NCT00227266 - Valproic Acid and Carnitine in Patients With Spinal Muscular Atrophy Phase 2
Completed NCT00374075 - Study of Safety and Dosing Effect on SMN Levels of Valproic Acid (VPA) in Patients With Spinal Muscular Atrophy Phase 1
Enrolling by invitation NCT05539456 - Reliability and Validity of the Turkish Version of the PedsQL 3.0 Neuromuscular Module for 2-to 4- Year-old
Recruiting NCT05779956 - Personalized Medicine for SMA: a Translational Project
Recruiting NCT03300869 - Natural History of Types 2 and 3 SMA in Taiwan
Recruiting NCT03217578 - Neonatal Spinal Muscular Atrophy (SMA) Screening
Completed NCT01703988 - An Open-label Safety, Tolerability and Dose-Range Finding Study of Multiple Doses of Nusinersen (ISIS 396443) in Participants With Spinal Muscular Atrophy Phase 1/Phase 2
Withdrawn NCT02235090 - Study of Feasibility to Reliably Measure Functional Abilities' Changes in Nonambulant Neuromuscular Patients Without Trial Site Visiting N/A
Completed NCT02123186 - Newborn Screening for Spinal Muscular Atrophy N/A
Completed NCT00756821 - A Pilot Study of Biomarkers for Spinal Muscular Atrophy N/A
Completed NCT00004771 - Phase II Study of Leuprolide and Testosterone for Men With Kennedy's Disease or Other Motor Neuron Disease Phase 2
Recruiting NCT05366465 - Quality of Life and Participation of the Adult With Spinal Muscular Atrophy in France
Recruiting NCT06310421 - Spinal Muscular Atrophy Neonatal Screening Program